Early pathogenic care and the development of ADHD-like symptoms

Brigitte Dahmen1, Vanessa Pütz, Beate Herpertz-Dahlmann

  • 1Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Medical Faculty, RWTH Aachen University, Neuenhofer Weg 21, 52074 Aachen, Germany. bdahmen@ukaachen.de

Insights

Early pathogenic care can cause developmental disorders like reactive attachment disorder (RAD), leading to ADHD-like symptoms. Research suggests brain circuit dysfunction, not true ADHD, may explain these behavioral similarities in children with adverse early experiences.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Child Psychiatry

Background:

  • Early pathogenic care, marked by emotional neglect, severely impacts psychosocial, cognitive, and brain development.
  • Reactive attachment disorder (RAD) is a condition linked to pathogenic care, featuring disturbed social interactions.
  • Children with RAD often exhibit symptoms similar to attention deficit/hyperactivity disorder (ADHD), raising questions about comorbidity versus phenocopy.

Purpose of the Study:

  • To review the neurobiological effects of early pathogenic care.
  • To explore whether ADHD-like symptoms in children with pathogenic care history are true ADHD or a phenocopy.
  • To provide treatment suggestions for ADHD-like symptoms in children with adverse early life experiences.

Main Methods:

  • Review of existing studies on the neurobiological consequences of early pathogenic care.
  • Analysis of research comparing ADHD-like symptoms in children with pathogenic care to established ADHD criteria.
  • Examination of neurodevelopmental pathways, focusing on limbic and prefrontal brain circuits.

Main Results:

  • Early pathogenic care can lead to dysfunction in limbic brain circuits.
  • This limbic dysfunction may interfere with prefrontal executive functions, causing behavioral similarities to ADHD.
  • The complex phenotype is potentially better understood through a dimensional approach reflecting early experiences.

Conclusions:

  • ADHD-like symptoms in children exposed to pathogenic care may stem from neurobiological changes in brain circuits, resembling ADHD but potentially having a different developmental origin.
  • A dimensional perspective incorporating early life experiences is crucial for understanding these complex behavioral and neurobiological presentations.
  • Evidence supports tailored treatment strategies for ADHD-like symptoms in children with histories of adverse early care.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...